Stocks and Investing
Stocks and Investing
Fri, July 19, 2024
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Evan David Seigerman Maintained (ABBV) at Buy with Increased Target to $214 on, Jul 19th, 2024
Evan David Seigerman of BMO Capital, Maintained "AbbVie Inc." (ABBV) at Buy with Increased Target from $180 to $214 on, Jul 19th, 2024.
Evan has made no other calls on ABBV in the last 4 months.
There are 6 other peers that have a rating on ABBV. Out of the 6 peers that are also analyzing ABBV, 0 agree with Evan's Rating of Hold.
These are the ratings of the 6 analyists that currently disagree with Evan
- Terence Flynn of "Morgan Stanley" Maintained at Buy with Increased Target to $196 on, Thursday, July 11th, 2024
- Louise Chen of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $200 on, Tuesday, July 9th, 2024
- Christopher Raymond of "Piper Sandler" Maintained at Buy and Held Target at $190 on, Tuesday, July 2nd, 2024
- Rajesh Kumar of "HSBC" Upgraded from Hold to Strong Buy and Held Target at $185 on, Wednesday, June 5th, 2024
- Carter Gould of "Barclays" Maintained at Buy with Decreased Target to $187 on, Monday, April 29th, 2024
- Vamil Divan of "Guggenheim" Maintained at Strong Buy with Increased Target to $190 on, Friday, March 22nd, 2024
Contributing Sources